COMPANY · NIPC 503099660

DECOMED FARMACEUTICA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €8,963,108.30 across 655 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameDECOMED FARMACEUTICA
NIPC503099660

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €137,27720122014: €117,296.992015: €220,963.2920152016: €17,0002017: €3,57020172018: €1502019: €293,086.4720192020: €346,155.812021: €545,893.2520212022: €1,488,876.162023: €1,785,121.8920232024: €1,793,763.952025: €1,268,704.8320252026: €945,248.66€1,793,763.95
Contracted value by year
YearContractsContract value
20124€137,277
201410€117,296.99
201513€220,963.29
20161€17,000
20171€3,570
20181€150
201925€293,086.47
202047€346,155.81
202187€545,893.25
202267€1,488,876.16
202373€1,785,121.89
2024125€1,793,763.95
2025118€1,268,704.83
202683€945,248.66
Contracted value by place of performance
NameContractsContract value
Setúbal56€4,068,266.02
Lisboa109€1,282,217.79
Coimbra71€932,941.90
Porto125€337,252.20
Santarém18€264,527.86
Almada26€214,536.27
Viseu30€167,989.08
Oeiras13€156,671.98
Braga10€147,009.56
Matosinhos4€141,538.41
Largest contracts
SubjectYearContract value
Medicamentos de Aquisição Centralizada2023€996,137.70
Medicamentos Cerebrospinal_SPMS_Bianual_2022_20232022€442,462.95
Vários medicamentos2022€202,171.43
AJUSTE DIRETO PARA A AQUISIÇÃO DE CABAZITAXEL [60 MG/1.5 ML; SOL INJ; FRS], NILUTAMIDA [150 MG; CÁP/COMP], NILUTAMIDA [50MG; CÁP/COMP] E PLERIXAFOR [20 MG/ML;1,2 ML; F/AMP] PARA AS INSTITUIÇÕES DO SNS2019€148,570.02
Vários Medicamentos2022€132,122.07

Who they competed with

In 107 contracts with a list of competitors, the company took part and was awarded 22 (21%).

Companies with the most procedures in common
CompanyProcedures in common
Generis, Lda.8
Laboratórios Vitória, S.A.6
Bial-Portela & Ca, S.A.6
Labesfal, S.A.6
Teva Pharma - Prod.Farmacêuticos6
B.BRAUN MEDICAL, LDA5
Bayer Portugal S. A.4
Mylan, Lda4
Ciclum Farma Unipessoal, Lda4
Overpharma, Lda.4
Sandoz, Lda.4
Sanofi-produtos farmacêuticos, Lda.3
LABORATÓRIOS PFIZER, LDA.3
Jaba Recordati3
DILOFAR - DISTRIBUIÇÃO TRANSPORTES LOGISTICA, LDA3
DAIICHI SANKYO PORTUGAL UNIPESSOAL, LDA.3
Ratiopharm, LDA3
ALLOGA LOGIFARMA, SA3
Teofarma S.R.L.3
Perrigo Portugal, Lda.3
BDRpharma, Lda3
LABORATÓRIOS INIBSA, SA.2
LILLY PORTUGAL - PRODUTOS FARMACEUTICOS2
Merck Sharp e Dohme Lda.2
LABORATÓRIO MEDINFAR - PRODUTOS2
Merck, SA2
Sidefarma, S.A.2
NOVO NORDISK COMERCIO PRODUTOS FARMACEUTICOS2
DISTRIFARMA-COMPANHIA DE DISTRIBUIÇÃO FARMACÊUTICA, S.A.2
Baxter Médico Farmacêutica, Lda.2

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents45 companies and 60 links. The list below gives the same content as text.Bayer Portugal… (NIPC 500043256)Bayer Portugal…Sanofi-produto… (NIPC 500134960)Sanofi-produto…LABORATÓRIOS P… (NIPC 500162166)LABORATÓRIOS P…LILLY PORTUGAL… (NIPC 500165602)LILLY PORTUGAL…Merck Sharp e … (NIPC 500191360)Merck Sharp e …LABORATÓRIO ME… (NIPC 500384045)LABORATÓRIO ME…Jaba Recordati (NIPC 500492867)Jaba RecordatiLabesfal, S.A. (NIPC 501169580)Labesfal, S.A.B.BRAUN MEDICA… (NIPC 501506543)B.BRAUN MEDICA…Mylan, Lda (NIPC 502248793)Mylan, LdaNIPC 503099660 (NIPC 503099660)NIPC 503099660+34 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.